Overview
Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children
Status:
Recruiting
Recruiting
Trial end date:
2021-12-31
2021-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of the study is to compare the effect of melatonin, given orally, dexmedetomidine, given intranasally, and dexmedetomidine given sublingually on sleep induction, sleep duration, their possible impact on vital functions and technical implementation of EEG.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University Medical Centre LjubljanaTreatments:
Dexmedetomidine
Melatonin
Criteria
Inclusion Criteria:- Age between 1 and 20 years
- Referral for EEG in sleep
- Children/young adults whose parents/caregivers were informed about the aims of the
study and have signed the Informed consent form
Exclusion Criteria:
- Children that were unable to follow the study protocol were excluded during the study